1-(3-三氟甲基苯基)乙醇 | 454-91-1

• 物质功能分类: 化学试剂 - 有机试剂 - 芳香醇
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(3-三氟甲基苯基)乙醇
• 中文别名: 1-甲基-3-三氟甲基苯乙醇；1-[3-(三氟甲基)苯基]乙醇；α-甲基-3-(三氟甲基)苯甲基醇
• 英文名称: 1-(3-trifluoromethylphenyl)ethanol
• 英文别名: 1-(3-(trifluoromethyl)phenyl)ethan-1-ol；α-methyl-3-trifluoromethylbenzyl alcohol；1-(3-(Trifluoromethyl)phenyl)ethanol；1-[3-(trifluoromethyl)phenyl]ethanol
• CAS: 454-91-1
• 化学式: C₉H₉F₃O
• 分子量: 190.165
• InChiKey: YNVXCOKNHXMBQC-UHFFFAOYSA-N

物化性质

• 沸点：
  100-102 °C17 mm Hg(lit.)
• 密度：
  1.249 g/mL at 25 °C(lit.)
• 闪点：
  205 °F
• 稳定性/保质期：
  按规格使用和存储，不会发生分解，并应避免与氧化物接触。

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  FLAMMABLE
• 危险品标志：
  F,Xi
• 安全说明：
  S24/25
• 危险类别码：
  R36/37/38
• WGK Germany：
  3
• 海关编码：
  29062990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  请将密封保存，并置于通风干燥处，避免与其它氧化物接触。

SDS

Name:	alpha-Methyl-3-(trifluoromethyl)benzyl alcohol 96% Material Safety Data Sheet
Synonym:
CAS:	454-91-1

Section 1 - Chemical Product MSDS Name:alpha-Methyl-3-(trifluoromethyl)benzyl alcohol 96% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
454-91-1	alpha-Methyl-3-(trifluoromethyl)benzyl	96%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Combustible liquid.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam. Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Avoid contact with skin and eyes. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 454-91-1: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 100 - 102 deg C @ 1
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: 96 deg C ( 204.80 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.2490g/cm3
Molecular Formula: CF3C6H4CH(CH3)OH
Molecular Weight: 190.17

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 454-91-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
alpha-Methyl-3-(trifluoromethyl)benzyl alcohol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 454-91-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 454-91-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 454-91-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

合成制备方法

暂无相关信息

用途

暂无相关信息

反应信息

• 作为反应物：
  描述：

  1-(3-三氟甲基苯基)乙醇 在 氯化亚砜 作用下， 生成 1-chloro-1-(3-trifluoromethylphenyl)ethane
  参考文献：
  名称：

  EP838452

  摘要：

  公开号：
• 作为产物：
  描述：

  间三氟甲基苯乙烯 在 硫酸 作用下， 生成 1-(3-三氟甲基苯基)乙醇
  参考文献：
  名称：

  Addition of trifluoroacetic acid to substituted styrenes

  摘要：

  DOI：

  10.1021/jo00143a011

文献信息

• [EN] 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY<br/>[FR] 2,4-DIAMINOQUINAZOLINES UTILES POUR LE TRAITEMENT D'UNE ATROPHIE MUSCULAIRE SPINALE
  申请人：DECODE CHEMISTRY INC

  公开号：WO2005123724A1

  公开（公告）日：2005-12-29

  2,4-Diaminoquinazolines of formulae I-IV and VI (I, II, III, IV and VI) are useful for treating spinal muscular atrophy (SMA).

  2,4-二氨基喹唑啉的化学式I-IV和VI（I，II，III，IV和VI）可用于治疗脊髓性肌萎缩症（SMA）。
• Manganese-catalyzed homogeneous hydrogenation of ketones and conjugate reduction of α,β-unsaturated carboxylic acid derivatives: A chemoselective, robust, and phosphine-free in situ-protocol
  作者：Thomas Vielhaber、Christoph Topf

  DOI：10.1016/j.apcata.2021.118280

  日期：2021.8

  glove-box-free catalytic protocol for the manganese-catalyzed hydrogenation of ketones and conjugated CCbonds of esters and nitriles. The respective catalyst is readily assembled in situ from the privileged [Mn(CO)5Br] precursor and cheap 2-picolylamine. The catalytic transformations were performed in the presence of t-BuOK whereby the corresponding hydrogenation products were obtained in good to excellent yields

  我们传达了一种用户友好且无需手套箱的催化协议，用于酮和酯和腈的共轭 C C键的锰催化氢化。相应的催化剂很容易由特权 [Mn(CO) 5 Br] 前体和廉价的 2-吡啶甲胺原位组装。催化转化在t- BuOK存在下进行，从而以良好至极好的收率获得相应的氢化产物。所描述的系统提供了对仲醇和饱和酯的快速和原子效率的访问，避免了使用氧敏感和昂贵的基于膦的配体。
• Cyclometalated iridium complexes for transfer hydrogenation of carbonyl groups in water
  作者：Yawen Wei、Dong Xue、Qian Lei、Chao Wang、Jianliang Xiao

  DOI：10.1039/c2gc36619c

  日期：——

  Cyclometalated iridium complexes are shown to be excellent catalysts for transfer hydrogenation of carbonyl compounds in water using formate as a hydrogen source. A wide range of ketones and aldehydes have been reduced at 0.05% catalyst loading with no need for any organic solvents. Solution pH is found to play a critical role, with acidic conditions needed for fast transfer hydrogenation.

  环金属化铱配合物表现出色 催化剂 转让 氢化 的 羰基化合物 在 水用甲酸作为氢源。范围广泛的酮类 和 醛类 降低了0.05％ 催化剂 无需任何有机物即可装载 溶剂。发现溶液的pH值起着至关重要的作用，而酸性条件是快速转移所必需的氢化。
• Use of diamines containing the α-phenylethyl group as chiral ligands in the asymmetric hydrosilylation of prochiral ketones
  作者：Virginia M. Mastranzo、Leticia Quintero、Cecilia Anaya de Parrodi、Eusebio Juaristi、Patrick J. Walsh

  DOI：10.1016/j.tet.2003.12.039

  日期：2004.2

  Chiral diamines 1–7 were used in the enantioselective hydrosilylation of prochiral aromatic and aliphatic ketones. Some of these ligands combine chiral backbones and chiral N,N′-α-phenylethyl substituents that give rise to synergistic effects between these two groups and lead to catalysts that exhibit high enantioselectivity.

  手性二胺1 – 7用于手性芳族和脂肪族酮的对映选择性氢化硅烷化。一些这些配体的结合的手性主链和手性Ñ，Ñ '-α苯乙基取代基产生两组与引线之间的协同效应，以表现出高对映选择性的催化剂。
• Pyridine‐Stabilized Rhodium Nanoparticles in Ionic Liquids as Selective Hydrogenation and Transfer Hydrogenation Catalysts
  作者：Alejandro Serrano‐Maldonado、Erika Martin、Itzel Guerrero‐Ríos

  DOI：10.1002/ejic.201900223

  日期：2019.6.30

  selectivity. Nitrobenzene was reduced to aniline with dihydrogen in the presence of RhNPs‐I with moderate activity. When the hydrogen source was formic acid‐Et3N azeotrope (transfer hydrogenation) the reaction was completed within minutes with high selectivity. Under transfer hydrogenation conditions, it was possible to apply the catalytic system RhNPs‐I in multistep processes for the generation of substituted

  在有机氢前体[Rh（µOMe）COD] 2下，在离子液体[BMIM] [BF 4 ]（RhNPs-I至III）中用吡啶基配体稳定的铑纳米颗粒（RhNPs）是由二氢压力合成的。与不含配体的RhNPs-V相比，吡啶稳定的RhNPs尺寸更小，并且在苯乙酮加氢成1-苯基乙醇中表现出更高的活性和选择性。如果使用吡啶封端的RhNPs-I，则该系统可重复使用几次，而不会损失活性和选择性。在RhNPs-I存在下，硝基苯将硝基苯与二氢还原为苯胺适度活动。当氢源为甲酸-Et 3 N共沸物（转移氢化）时，反应可在数分钟内以高选择性完成。在转移加氢条件下，可以将催化体系RhNPs-I应用于多步过程中，通过硝基苯和苯甲醛的还原性N-烷基化反应生成取代的芳基胺。并通过硝基芳烃还原/ Paal-Knorr缩合合成取代的吡咯。